Brief: Nls Pharmaceutics AG Regained Compliance With Nasdaq's Minimum Bid Price Requirement
10/10/2024 21:11
NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS AG: REGAINED COMPLIANCE WITH NASDAQ'S
MINIMUM
BID PRICE REQUIREMENT
Source text for Eikon: ID:n0001213900-24-086884
Further company coverage: NLSP.O
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing